Contact

All Stories

  1. Sequencing and combination of current small‐molecule inhibitors for chronic lymphocytic leukemia: Where is the evidence?

    Article • European Journal Of Haematology, April 2023, Wiley

    Dr. Clement Chung

  2. Optimizing Multidisciplinary Treatment-Related Adverse Effects Detection and Reduction in Patients Undergoing Active Cancer Treatments in Ambulatory Infusion Centers

    Article • JCO Oncology Practice, September 2022, American Society of Clinical Oncology (ASCO)

    Dr. Clement Chung

  3. Prognostic and predictive biomarkers with therapeutic targets in breast cancer: A 2022 update on current developments, evidence, and recommendations

    Article • Journal of Oncology Pharmacy Practice, August 2022, SAGE Publications

    Dr. Clement Chung

  4. A Promising Future for Precision Epigenetic Therapy for Follicular and Diffuse Large B-Cell Lymphoma?

    Article • Blood and Lymphatic Cancer Targets and Therapy, August 2022, Taylor & Francis

    Dr. Clement Chung

  5. Targeting the Myeloid Lineages and the Immune Microenvironment in Myelodysplastic Syndromes: Novel and Evolving Therapeutic Strategies

    Article • Annals of Pharmacotherapy, July 2021, SAGE Publications

    Dr. Clement Chung

  6. Predictive and prognostic biomarkers with therapeutic targets in colorectal cancer: A 2021 update on current development, evidence, and recommendation

    Article • Journal of Oncology Pharmacy Practice, April 2021, SAGE Publications

    Dr. Clement Chung

  7. From oxygen sensing to angiogenesis: Targeting the hypoxia signaling pathway in metastatic kidney cancer

    Article • American Journal of Health-System Pharmacy, October 2020, Oxford University Press (OUP)

    Dr. Clement Chung

  8. New Therapeutic Targets and Treatment Options for Thrombotic Microangiopathy: Caplacizumab and Ravulizumab

    Article • Annals of Pharmacotherapy, July 2020, SAGE Publications

    Dr. Clement Chung

  9. Driving toward precision medicine for B cell lymphomas: Targeting the molecular pathogenesis at the gene level

    Article • Journal of Oncology Pharmacy Practice, January 2020, SAGE Publications

    Dr. Clement Chung

  10. Current targeted therapies in lymphomas

    Article • American Journal of Health-System Pharmacy, October 2019, Oxford University Press (OUP)

    Dr. Clement Chung

  11. Instilling value, quality, and safety through hematology and oncology stewardship

    Article • American Journal of Health-System Pharmacy, March 2019, Oxford University Press (OUP)

    Dr. Clement Chung

  12. To do or not to do: A concise update of current clinical controversies in immune checkpoint blockade

    Article • Journal of Oncology Pharmacy Practice, July 2018, SAGE Publications

    Dr. Clement Chung

  13. Restoring the switch for cancer cell death: Targeting the apoptosis signaling pathway

    Article • American Journal of Health-System Pharmacy, July 2018, Oxford University Press (OUP)

    Dr. Clement Chung

  14. Implementation of an integrated computerized prescriber order-entry system for chemotherapy in a multisite safety-net health system

    Article • American Journal of Health-System Pharmacy, March 2018, Oxford University Press (OUP)

    Dr. Clement Chung

  15. Older adults may not consider life expectancy an important factor in cancer screening

    Article • CA A Cancer Journal for Clinicians, November 2017, Wiley

    Dr. Clement Chung

  16. Risk of ovarian function recovery should be considered when switching from treatment with adjuvant tamoxifen to aromatase inhibitor therapy in women with chemotherapy-induced amenorrhea

    Article • CA A Cancer Journal for Clinicians, November 2017, Wiley

    Dr. Clement Chung

  17. Driving Toward Precision Medicine for Acute Leukemias: Are We There Yet?

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, July 2017, Wiley

    Dr. Clement Chung

  18. New treatment options for multiple myeloma based on principles utilizing immunotherapy

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, January 2017, Wiley

    Dr. Clement Chung

  19. Management of neuroendocrine tumors

    Article • American Journal of Health-System Pharmacy, October 2016, American Society of Health System Pharmacists

    Dr. Clement Chung

  20. An update on current and emerging therapies for epithelial ovarian cancer: Focus on poly(adenosine diphosphate-ribose) polymerase inhibition and antiangiogenesis

    Article • Journal of Oncology Pharmacy Practice, June 2016, SAGE Publications

    Dr. Clement Chung

  21. Importance of ethnicity and smoking status in EGFR gene testing in lung cancers

    Article • American Journal of Health-System Pharmacy, May 2015, Oxford University Press (OUP)

    Dr. Clement Chung

  22. Tyrosine kinase inhibitors for epidermal growth factor receptor gene mutation–positive non-small cell lung cancers: an update for recent advances in therapeutics

    Article • Journal of Oncology Pharmacy Practice, April 2015, SAGE Publications

    Dr. Clement Chung

  23. Trametinib: A novel signal transduction inhibitor for the treatment of metastatic cutaneous melanoma

    Article • American Journal of Health-System Pharmacy, December 2014, American Society of Health System Pharmacists

    Dr. Clement Chung

  24. Ibrutinib, Obinutuzumab, Idelalisib, and Beyond: Review of Novel and Evolving Therapies for Chronic Lymphocytic Leukemia

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, October 2014, Wiley

    Dr. Clement Chung

  25. Predictive and prognostic biomarkers with therapeutic targets in breast, colorectal, and non-small cell lung cancers: A systemic review of current development, evidence, and recommendation

    Article • Journal of Oncology Pharmacy Practice, February 2014, SAGE Publications

    Dr. Clement Chung

  26. Omacetaxine for treatment-resistant or treatment-intolerant adult chronic myeloid leukemia

    Article • American Journal of Health-System Pharmacy, January 2014, American Society of Health System Pharmacists

    Dr. Clement Chung

  27. Ziv-aflibercept: A novel angiogenesis inhibitor for the treatment of metastatic colorectal cancer

    Article • American Journal of Health-System Pharmacy, October 2013, American Society of Health System Pharmacists

    Dr. Clement Chung

  28. Pertuzumab for the treatment of human epidermal growth factor receptor type 2-positive metastatic breast cancer

    Article • American Journal of Health-System Pharmacy, August 2013, American Society of Health System Pharmacists

    Dr. Clement Chung

  29. Development and implementation of an interdisciplinary oncology program in a community hospital

    Article • American Journal of Health-System Pharmacy, August 2011, American Society of Health System Pharmacists

    Dr. Clement Chung